TY - JOUR AU - Huynh, K. AU - Bernardo, B. C. AU - McMullen, J. R. AU - Ritchie, R. H. PY - 2014 DA - 2014// TI - Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways JO - Pharmacol Ther VL - 142 UR - https://doi.org/10.1016/j.pharmthera.2014.01.003 DO - 10.1016/j.pharmthera.2014.01.003 ID - Huynh2014 ER - TY - JOUR AU - Radovits, T. AU - Korkmaz, S. AU - Loganathan, S. PY - 2009 DA - 2009// TI - Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus JO - Am J Physiol Heart Circ Physiol VL - 297 UR - https://doi.org/10.1152/ajpheart.00165.2009 DO - 10.1152/ajpheart.00165.2009 ID - Radovits2009 ER - TY - JOUR AU - Radovits, T. AU - Bomicke, T. AU - Kokeny, G. PY - 2009 DA - 2009// TI - The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus JO - Br J Pharmacol VL - 156 UR - https://doi.org/10.1111/j.1476-5381.2008.00098.x DO - 10.1111/j.1476-5381.2008.00098.x ID - Radovits2009 ER - TY - JOUR AU - Poirier, P. AU - Bogaty, P. AU - Garneau, C. AU - Marois, L. AU - Dumesnil, J. G. PY - 2001 DA - 2001// TI - Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy JO - Diabetes Care VL - 24 UR - https://doi.org/10.2337/diacare.24.1.5 DO - 10.2337/diacare.24.1.5 ID - Poirier2001 ER - TY - JOUR AU - Joffe, I. I. AU - Travers, K. E. AU - Perreault-Micale, C. L. PY - 1999 DA - 1999// TI - Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway JO - J Am Coll Cardiol VL - 34 UR - https://doi.org/10.1016/S0735-1097(99)00436-2 DO - 10.1016/S0735-1097(99)00436-2 ID - Joffe1999 ER - TY - JOUR AU - Sharma, V. AU - McNeill, J. H. PY - 2006 DA - 2006// TI - Diabetic cardiomyopathy: where are we 40 years later? JO - Can J Cardiol VL - 22 UR - https://doi.org/10.1016/S0828-282X(06)70914-X DO - 10.1016/S0828-282X(06)70914-X ID - Sharma2006 ER - TY - JOUR AU - Mourmoura, E. AU - Vial, G. AU - Laillet, B. PY - 2013 DA - 2013// TI - Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-49 DO - 10.1186/1475-2840-12-49 ID - Mourmoura2013 ER - TY - JOUR AU - Pearson, J. T. AU - Jenkins, M. J. AU - Edgley, A. J. PY - 2013 DA - 2013// TI - Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-111 DO - 10.1186/1475-2840-12-111 ID - Pearson2013 ER - TY - JOUR AU - Cai, L. PY - 2006 DA - 2006// TI - Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy JO - Free Radic Biol Med VL - 41 UR - https://doi.org/10.1016/j.freeradbiomed.2006.06.007 DO - 10.1016/j.freeradbiomed.2006.06.007 ID - Cai2006 ER - TY - JOUR AU - Moncada, S. AU - Palmer, R. M. AU - Higgs, E. A. PY - 1991 DA - 1991// TI - Nitric oxide: physiology, pathophysiology, and pharmacology JO - Pharmacol Rev VL - 43 ID - Moncada1991 ER - TY - JOUR AU - Radovits, T. AU - Arif, R. AU - Bomicke, T. PY - 2013 DA - 2013// TI - Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil JO - Eur J Pharmacol VL - 710 UR - https://doi.org/10.1016/j.ejphar.2013.04.012 DO - 10.1016/j.ejphar.2013.04.012 ID - Radovits2013 ER - TY - JOUR AU - Szabo, G. AU - Radovits, T. AU - Veres, G. PY - 2009 DA - 2009// TI - Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass JO - Eur J Cardiothorac Surg VL - 36 UR - https://doi.org/10.1016/j.ejcts.2009.03.065 DO - 10.1016/j.ejcts.2009.03.065 ID - Szabo2009 ER - TY - JOUR AU - Hirschberg, K. AU - Radovits, T. AU - Loganathan, S. PY - 2009 DA - 2009// TI - Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy JO - J Thorac Cardiovasc Surg VL - 137 UR - https://doi.org/10.1016/j.jtcvs.2008.10.016 DO - 10.1016/j.jtcvs.2008.10.016 ID - Hirschberg2009 ER - TY - JOUR AU - Loganathan, S. AU - Radovits, T. AU - Hirschberg, K. PY - 2008 DA - 2008// TI - Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation JO - Transplantation VL - 86 UR - https://doi.org/10.1097/TP.0b013e31818aa34e DO - 10.1097/TP.0b013e31818aa34e ID - Loganathan2008 ER - TY - JOUR AU - Kukreja, R. C. AU - Salloum, F. N. AU - Das, A. PY - 2012 DA - 2012// TI - Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection JO - J Am Coll Cardiol VL - 59 UR - https://doi.org/10.1016/j.jacc.2011.09.086 DO - 10.1016/j.jacc.2011.09.086 ID - Kukreja2012 ER - TY - JOUR AU - Schafer, A. AU - Fraccarollo, D. AU - Pfortsch, S. PY - 2008 DA - 2008// TI - Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus JO - Br J Pharmacol VL - 153 UR - https://doi.org/10.1038/sj.bjp.0707459 DO - 10.1038/sj.bjp.0707459 ID - Schafer2008 ER - TY - JOUR AU - Stasch, J. P. AU - Schmidt, P. M. AU - Nedvetsky, P. I. PY - 2006 DA - 2006// TI - Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI28371 DO - 10.1172/JCI28371 ID - Stasch2006 ER - TY - JOUR AU - Korkmaz, S. AU - Radovits, T. AU - Barnucz, E. PY - 2009 DA - 2009// TI - Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.870774 DO - 10.1161/CIRCULATIONAHA.109.870774 ID - Korkmaz2009 ER - TY - JOUR AU - Radovits, T. AU - Korkmaz, S. AU - Miesel-Groschel, C. PY - 2011 DA - 2011// TI - Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass JO - Eur J Cardiothorac Surg VL - 39 UR - https://doi.org/10.1016/j.ejcts.2010.05.025 DO - 10.1016/j.ejcts.2010.05.025 ID - Radovits2011 ER - TY - JOUR AU - Salloum, F. N. AU - Das, A. AU - Samidurai, A. PY - 2012 DA - 2012// TI - Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide JO - Am J Physiol Heart Circ Physiol VL - 302 UR - https://doi.org/10.1152/ajpheart.00544.2011 DO - 10.1152/ajpheart.00544.2011 ID - Salloum2012 ER - TY - JOUR AU - Korkmaz, S. AU - Loganathan, S. AU - Mikles, B. PY - 2013 DA - 2013// TI - Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta JO - J Cardiovasc Pharmacol Ther VL - 18 UR - https://doi.org/10.1177/1074248412455696 DO - 10.1177/1074248412455696 ID - Korkmaz2013 ER - TY - JOUR AU - Hirschberg, K. AU - Tarcea, V. AU - Pali, S. PY - 2013 DA - 2013// TI - Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation JO - Int J Cardiol VL - 167 UR - https://doi.org/10.1016/j.ijcard.2012.01.032 DO - 10.1016/j.ijcard.2012.01.032 ID - Hirschberg2013 ER - TY - JOUR AU - Irvine, J. C. AU - Ganthavee, V. AU - Love, J. E. PY - 2012 DA - 2012// TI - The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0044481 DO - 10.1371/journal.pone.0044481 ID - Irvine2012 ER - TY - JOUR AU - Frey, R. AU - Muck, W. AU - Unger, S. AU - Artmeier-Brandt, U. AU - Weimann, G. AU - Wensing, G. PY - 2008 DA - 2008// TI - Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers JO - J Clin Pharmacol VL - 48 UR - https://doi.org/10.1177/0091270008322906 DO - 10.1177/0091270008322906 ID - Frey2008 ER - TY - JOUR AU - Lapp, H. AU - Mitrovic, V. AU - Franz, N. PY - 2009 DA - 2009// TI - Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure JO - Circulation VL - 119 UR - https://doi.org/10.1161/CIRCULATIONAHA.108.800292 DO - 10.1161/CIRCULATIONAHA.108.800292 ID - Lapp2009 ER - TY - JOUR AU - Erdmann, E. AU - Semigran, M. J. AU - Nieminen, M. S. PY - 2013 DA - 2013// TI - Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/ehs196 DO - 10.1093/eurheartj/ehs196 ID - Erdmann2013 ER - TY - JOUR AU - Levy, P. D. AU - Laribi, S. AU - Mebazaa, A. PY - 2014 DA - 2014// TI - Vasodilators in acute heart failure: review of the latest studies JO - Curr Emerg Hosp Med Rep VL - 2 UR - https://doi.org/10.1007/s40138-014-0040-z DO - 10.1007/s40138-014-0040-z ID - Levy2014 ER - TY - JOUR AU - Gheorghiade, M. AU - Greene, S. J. AU - Filippatos, G. PY - 2012 DA - 2012// TI - Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes JO - Eur J Heart Fail VL - 14 UR - https://doi.org/10.1093/eurjhf/hfs093 DO - 10.1093/eurjhf/hfs093 ID - Gheorghiade2012 ER - TY - JOUR AU - Pacher, P. AU - Nagayama, T. AU - Mukhopadhyay, P. AU - Batkai, S. AU - Kass, D. A. PY - 2008 DA - 2008// TI - Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats JO - Nat Protoc VL - 3 UR - https://doi.org/10.1038/nprot.2008.138 DO - 10.1038/nprot.2008.138 ID - Pacher2008 ER - TY - JOUR AU - Radovits, T. AU - Olah, A. AU - Lux, A. PY - 2013 DA - 2013// TI - Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis JO - Am J Physiol Heart Circ Physiol VL - 305 UR - https://doi.org/10.1152/ajpheart.00108.2013 DO - 10.1152/ajpheart.00108.2013 ID - Radovits2013 ER - TY - JOUR AU - Litwin, S. E. AU - Raya, T. E. AU - Anderson, P. G. AU - Daugherty, S. AU - Goldman, S. PY - 1990 DA - 1990// TI - Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle JO - J Clin Invest VL - 86 UR - https://doi.org/10.1172/JCI114734 DO - 10.1172/JCI114734 ID - Litwin1990 ER - TY - JOUR AU - Snoeckx, L. H. AU - Cornelussen, R. N. AU - Nieuwenhoven, F. A. AU - Reneman, R. S. AU - Vusse, G. J. PY - 2001 DA - 2001// TI - Heat shock proteins and cardiovascular pathophysiology JO - Physiol Rev VL - 81 ID - Snoeckx2001 ER - TY - JOUR AU - Pacher, P. AU - Beckman, J. S. AU - Liaudet, L. PY - 2007 DA - 2007// TI - Nitric oxide and peroxynitrite in health and disease JO - Physiol Rev VL - 87 UR - https://doi.org/10.1152/physrev.00029.2006 DO - 10.1152/physrev.00029.2006 ID - Pacher2007 ER - TY - JOUR AU - Lukowski, R. AU - Krieg, T. AU - Rybalkin, S. D. AU - Beavo, J. AU - Hofmann, F. PY - 2014 DA - 2014// TI - Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond JO - Trends Pharmacol Sci VL - 35 UR - https://doi.org/10.1016/j.tips.2014.05.003 DO - 10.1016/j.tips.2014.05.003 ID - Lukowski2014 ER - TY - JOUR AU - Fang, L. AU - Radovits, T. AU - Szabo, G. AU - Mozes, M. M. AU - Rosivall, L. AU - Kokeny, G. PY - 2013 DA - 2013// TI - Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes JO - Nephrol Dial Transplant VL - 28 UR - https://doi.org/10.1093/ndt/gfs391 DO - 10.1093/ndt/gfs391 ID - Fang2013 ER - TY - JOUR AU - Hamet, P. AU - Pang, S. C. AU - Tremblay, J. PY - 1989 DA - 1989// TI - Atrial natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells JO - J Biol Chem VL - 264 ID - Hamet1989 ER - TY - JOUR AU - Koka, S. AU - Das, A. AU - Salloum, F. N. AU - Kukreja, R. C. PY - 2013 DA - 2013// TI - Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice JO - Free Radic Biol Med VL - 60 UR - https://doi.org/10.1016/j.freeradbiomed.2013.01.031 DO - 10.1016/j.freeradbiomed.2013.01.031 ID - Koka2013 ER - TY - JOUR AU - Bugger, H. AU - Abel, E. D. PY - 2014 DA - 2014// TI - Molecular mechanisms of diabetic cardiomyopathy JO - Diabetologia VL - 57 UR - https://doi.org/10.1007/s00125-014-3171-6 DO - 10.1007/s00125-014-3171-6 ID - Bugger2014 ER - TY - JOUR AU - Linthout, S. AU - Seeland, U. AU - Riad, A. PY - 2008 DA - 2008// TI - Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy JO - Basic Res Cardiol VL - 103 UR - https://doi.org/10.1007/s00395-008-0715-2 DO - 10.1007/s00395-008-0715-2 ID - Linthout2008 ER - TY - JOUR AU - Cai, L. AU - Li, W. AU - Wang, G. AU - Guo, L. AU - Jiang, Y. AU - Kang, Y. J. PY - 2002 DA - 2002// TI - Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.6.1938 DO - 10.2337/diabetes.51.6.1938 ID - Cai2002 ER - TY - STD TI - Beyer C, Zenzmaier C, Palumbo-Zerr K, et al. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFbeta signalling. Ann Rheum Dis. 2014. doi: 10.1136/annrheumdis-2013-204508 (Published ahead of print 23 February 2014). ID - ref41 ER - TY - JOUR AU - Wang, S. AU - Mitu, G. M. AU - Hirschberg, R. PY - 2008 DA - 2008// TI - Osmotic polyuria: an overlooked mechanism in diabetic nephropathy JO - Nephrol Dial Transplant VL - 23 UR - https://doi.org/10.1093/ndt/gfn115 DO - 10.1093/ndt/gfn115 ID - Wang2008 ER -